A Phase II Randomized Double-Blinded Evaluation of Oral Everolimus (RAD001)Plus Bevacizumab vs. Oral Placebo Plus Bevacizumab in the Treatment of Recurrent or Persistent Epithelial Ovarian Fallopian Tube or Primary Peritoneal Cancer (IND #109657). GOG
-
- STATUS
- Not Recruiting
Summary
The main purpose of this study is to compare the effectiveness of the combination of drugs bevacizumab and everolimus to bevacizumab and placebo (sugar pill) in treating cancer and to determine the types and severity of side effects caused by treatment wi
Description
The main purpose of this study is to compare the effectiveness of the combination of drugs bevacizumab and everolimus to bevacizumab and placebo (sugar pill) in treating cancer and to determine the types and severity of side effects caused by treatment wi
Details
| Condition | Fallopian Tube |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX1496 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.